
|Videos|December 2, 2020
Single administration of intracameral bimatoprost implant: IOP lowering, safety
Author(s)David Hutton, Alex Delaney-Gesing
Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.
Advertisement
Michael R. Robinson, MD, vice president, Global Therapeutic Area Head, Ophthalmology at Allergan, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye
2
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
3
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
4
Pterygium width may help predict corneal optical disturbance
5





















